Cargando…

Virus-Like Particle Vaccination Protects Nonhuman Primates from Lethal Aerosol Exposure with Marburgvirus (VLP Vaccination Protects Macaques against Aerosol Challenges)

Marburg virus (MARV) was the first filovirus to be identified following an outbreak of viral hemorrhagic fever disease in Marburg, Germany in 1967. Due to several factors inherent to filoviruses, they are considered a potential bioweapon that could be disseminated via an aerosol route. Previous stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dye, John M., Warfield, Kelly L., Wells, Jay B., Unfer, Robert C., Shulenin, Sergey, Vu, Hong, Nichols, Donald K., Aman, M. Javad, Bavari, Sina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848589/ https://www.ncbi.nlm.nih.gov/pubmed/27070636 http://dx.doi.org/10.3390/v8040094

Ejemplares similares

Homologous and Heterologous Protection of Nonhuman Primates by Ebola and Sudan Virus-Like Particles
por: Warfield, Kelly L., et al.
Publicado: (2015)

Discovery of common marburgvirus protective epitopes in a BALB/c mouse model
por: Kalina, Warren V, et al.
Publicado: (2009)

Deposition of Aerosolized Lucinactant in Nonhuman Primates
por: Gregory, Timothy J., et al.
Publicado: (2020)

Development of a model for marburgvirus based on severe-combined immunodeficiency mice
por: Warfield, Kelly L, et al.
Publicado: (2007)

T-cell-dependent mechanisms promote Ebola VLP-induced antibody responses, but are dispensable for vaccine-mediated protection
por: Cooper, Christopher L, et al.
Publicado: (2017)

A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates
por: Callendret, Benoit, et al.
Publicado: (2018)

Correction: A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates
por: Callendret, Benoit, et al.
Publicado: (2018)

A thermostable, chromatographically purified Ebola nano-VLP vaccine
por: Carra, John H, et al.
Publicado: (2015)

Serum antibody profiling identifies vaccine-induced correlates of protection against aerosolized ricin toxin in rhesus macaques
por: Roy, Chad J., et al.
Publicado: (2022)

Protective effect of an inactivated avian coronavirus vaccine administered by aerosol
por: Coria, M. F.
Publicado: (1973)

IRES-Containing VEEV Vaccine Protects Cynomolgus Macaques from IE Venezuelan Equine Encephalitis Virus Aerosol Challenge
por: Rossi, Shannan L., et al.
Publicado: (2015)

Protective Efficacy of Inhaled BCG Vaccination Against Ultra-Low Dose Aerosol M. tuberculosis Challenge in Rhesus Macaques
por: White, Andrew D., et al.
Publicado: (2020)

A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease
por: Foster, Stephanie L., et al.
Publicado: (2022)

A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge
por: Woolsey, Courtney, et al.
Publicado: (2022)

A Characterization of Aerosolized Sudan Virus Infection in African Green Monkeys, Cynomolgus Macaques, and Rhesus Macaques
por: Zumbrun, Elizabeth E., et al.
Publicado: (2012)

Correction: IRES-Containing VEEV Vaccine Protects Cynomolgus Macaques from IE Venezuelan Equine Encephalitis Virus Aerosol Challenge
Publicado: (2015)

A DNA vaccine targeting VEE virus delivered by needle-free jet-injection protects macaques against aerosol challenge
por: Suschak, John J., et al.
Publicado: (2022)

A VLP vaccine for epidemic Chikungunya virus protects non-human primates against infection
por: Akahata, Wataru, et al.
Publicado: (2010)

Role of Natural Killer Cells in Innate Protection against Lethal Ebola Virus Infection
por: Warfield, Kelly L., et al.
Publicado: (2004)

Second Generation Inactivated Eastern Equine Encephalitis Virus Vaccine Candidates Protect Mice against a Lethal Aerosol Challenge
por: Honnold, Shelley P., et al.
Publicado: (2014)

Therapeutic monoclonal antibody treatment protects nonhuman primates from severe Venezuelan equine encephalitis virus disease after aerosol exposure
por: Burke, Crystal W., et al.
Publicado: (2019)

Antibody Quality and Protection from Lethal Ebola Virus Challenge in Nonhuman Primates Immunized with Rabies Virus Based Bivalent Vaccine
por: Blaney, Joseph E., et al.
Publicado: (2013)

Use of Single-Injection Recombinant Vesicular Stomatitis Virus Vaccine to Protect Nonhuman Primates Against Lethal Nipah Virus Disease
por: Mire, Chad E., et al.
Publicado: (2019)

Multivalent vaccines demonstrate immunogenicity and protect against Coxiella burnetii aerosol challenge
por: Jan, Sharon, et al.
Publicado: (2023)

A Nonhuman Primate Scrub Typhus Model: Protective Immune Responses Induced by pKarp47 DNA Vaccination in Cynomolgus Macaques
por: Paris, Daniel H., et al.
Publicado: (2015)

MTBVAC vaccination protects rhesus macaques against aerosol challenge with M. tuberculosis and induces immune signatures analogous to those observed in clinical studies
por: White, Andrew D., et al.
Publicado: (2021)

A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice
por: Spohn, Gunther, et al.
Publicado: (2010)

Antibodies Are Major Drivers of Protection against Lethal Aerosol Infection with Highly Pathogenic Burkholderia spp.
por: Hogan, Robert J., et al.
Publicado: (2019)

A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates
por: Kari, Laszlo, et al.
Publicado: (2011)

Effects of Treatment Delay on Efficacy of Tecovirimat Following Lethal Aerosol Monkeypox Virus Challenge in Cynomolgus Macaques
por: Russo, Andrew T, et al.
Publicado: (2018)

Recent advances in marburgvirus research
por: Olejnik, Judith, et al.
Publicado: (2019)

Novel Structurally Designed Vaccine for S. aureus α-Hemolysin: Protection against Bacteremia and Pneumonia
por: Adhikari, Rajan P., et al.
Publicado: (2012)

A Monovalent and Trivalent MVA-Based Vaccine Completely Protects Mice Against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenge
por: Henning, Lisa, et al.
Publicado: (2021)

Vesicular Stomatitis Virus-Based Vaccines Protect Nonhuman Primates against Bundibugyo ebolavirus
por: Mire, Chad E., et al.
Publicado: (2013)

Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate
por: Roozendaal, Ramon, et al.
Publicado: (2020)

DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based Vaccines
por: Cabral-Miranda, Gustavo, et al.
Publicado: (2018)

High-dose Mycobacterium tuberculosis aerosol challenge cannot overcome BCG-induced protection in Chinese origin cynomolgus macaques; implications of natural resistance for vaccine evaluation
por: Sibley, Laura, et al.
Publicado: (2021)

An aerosol challenge model of tuberculosis in Mauritian cynomolgus macaques
por: Sharpe, S. A., et al.
Publicado: (2017)

Passive immunization with an extended half-life monoclonal antibody protects Rhesus macaques against aerosolized ricin toxin
por: Roy, Chad J., et al.
Publicado: (2020)

Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates
por: Hooper, J.W, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_gjuvnet86ffej6qh9nohvruf6e